Page last updated: 2024-10-24

carbazilquinone and Refractory Anemia

carbazilquinone has been researched along with Refractory Anemia in 1 studies

Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yonekura, S1
Nagao, T1
Arimori, S1

Other Studies

1 other study available for carbazilquinone and Refractory Anemia

ArticleYear
Essential thrombocythemia developing into refractory anemia and complicated by acute myeloid leukemia.
    Internal medicine (Tokyo, Japan), 1992, Volume: 31, Issue:10

    Topics: Aged; Anemia, Refractory; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Cytarabin

1992